TGFBI Antibody

Skip to product information
1 of 3

Selleck Chemicals

SKU:F1016-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

BETAIG-H3 is a target of interest in many antibody-based workflows. The extracellular matrix (ECM) is crucial in the tumor microenvironment, especially in metastatic colonization. Depletion of the matricellular protein TGFBI in MMTV-PyMT mice normalizes vasculature, reduces hypoxia, decreases CSC content, and lowers lung metastasis, highlighting TGFBI as a potential breast cancer target. Depending on the literature source, BETAIG-H3 may also be discussed as TGFBI.

Reported cellular context includes secreted and extracellular matrix, which can matter when signal is compared across treatments or changing cell states. Following BETAIG-H3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

BETAIG-H3 is commonly interpreted in the context of cancer and epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans secreted and extracellular matrix, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between secreted and extracellular matrix across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • links between target behavior and transcriptional or chromatin-state changes
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for BETAIG-H3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in BETAIG-H3 reflect biology rather than handling. When interpreting BETAIG-H3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep BETAIG-H3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
BETAIG-H3
Research Area:
Cancer • Epigenetics
Application:
IF • IHC • WB
Reactivity:
Human • Mouse • Rat
Specificity:
TGFBI Antibody [P17H24] detects endogenous levels of total TGFBI protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
P17H24
UniProt:
Q15582
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.